What is Balcoltra?
Balcoltra is the brand name for a medicine used to treat tuberous sclerosis complex (TSC). It contains everolimus, an mTOR inhibitor designed to reduce the growth of certain tumors associated with TSC. [1]
What does Balcoltra treat in tuberous sclerosis complex?
In TSC, Balcoltra is used for TSC-associated renal angiomyolipoma (kidney tumors) and can also be used for subependymal giant cell astrocytoma (SEGA) in appropriate patients. [1]
How does Balcoltra work?
Balcoltra contains everolimus, which blocks mTOR signaling. That pathway drives growth in some TSC-associated tumors, so reducing that signaling can shrink or slow tumor growth. [1]
How is Balcoltra taken?
The available information provided here identifies Balcoltra and its active ingredient, but it does not specify dosing instructions. If you share the form you have (tablet strength, or whether it is for kidney tumors vs SEGA) and the country you’re in, I can help interpret the typical prescribing approach using the correct local labeling.
What side effects are people concerned about?
The information provided here does not list side effects. Common everolimus concerns generally include mouth ulcers, infections, blood count changes, and metabolic effects, but I can’t confirm which ones are listed for Balcoltra specifically without the product insert.
Is Balcoltra a prescription medicine?
Balcoltra is a prescription medicine because it contains everolimus. [1]
---
Sources
[1] https://www.medicines.org.uk/emc/product/10490/smpc